HSR25-204: Clinical Characteristics and Prognosis Associated With Low PSA in Patients With De Novo Metastatic Hormone Sensitive Prostate Cancer

"HSR25-204: Clinical Characteristics and Prognosis Associated With Low PSA in Patients With De Novo Metastatic Hormone Sensitive Prostate Cancer" published on 28 Mar 2025 by National Comprehensive Cancer Network.

Authors

Institutions

Publication Details

Journal
Journal of the National Comprehensive Cancer Network
Published
2025-03-28
DOI
https://doi.org/10.6004/jnccn.2024.7318
Primary Topic
Prostate Cancer Treatment and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

HSR25-204: Clinical Characteristics and Prognosis Associated With Low PSA in Patients With De Novo Metastatic Hormone Sensitive Prostate Cancer

Cody McIntire, Morgan Puglisi, John W. Melson, Bohdan Baralo et al.
1 links
Journal of the National Comprehensive Cancer Network
Prostate Cancer Treatment and Research
article

HSR25-204: Clinical Characteristics and Prognosis Associated With Low PSA in Patients With De Novo Metastatic Hormone Sensitive Prostate Cancer

Cody McIntire, Morgan Puglisi, John W. Melson, Bohdan Baralo, Asit K. Paul, Peter T. Daniels, Natasha N. Dziarnowski
article en

Abstract

No abstract available for this paper.

Journal of the National Comprehensive Cancer NetworkVol. 23(3.5)
Virginia Commonwealth University (US)
Good health and well-being
Openalex Percentile: Top 91%
Prostate Cancer Treatment and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.